Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify, Tylenol autism cases, Jardiance cases connected to Fournier gangrene, or any other anti-psychotic medication cases. Thank you.
Select Page

Zimmer Biomet Update

3 min read

Introduction

Zimmer Biomet is a leading manufacturer of orthopedic and joint replacement equipment that sells over 1 million artificial hip, shoulder, and knee implants in the United States. These Zimmer Biomet hip, shoulder, and knee implants have faced a series of recalls the last several years, forcing litigation of the defective products. [1] these hip replacement implant devices are made up of prosthetic joints in pieces that are typically metal on metal technology.

Zimmer Biomet Recalls

Zimmer Biomet has filed at least 355 recalls for knee replacement devices since 2003, with the most coming in 2017. These lawsuits were consolidated in August 2011 in the Northern District of Illinois before Judge Rebecca Pallmeyer. One of the types of implant is known as the M2a Magnum Hip Implant. It was one of the most popular that was openly pushed by Biomet to be long lasting and revolutionary. However, when the metal parts rub against each other it creates microscopic shavings that are released into the hip joint, causing inflammation, loosening, and other problems that are associated with the metal hip poisoning. This has caused many of the users to undergo revisionist surgeries. These revisionist surgeries are supposed to correct the issues associated with the inflammation, and in some cases complete removal and replacement with another type of hip implant. [1]

Currently, the Biomet M2a Magnum Hip Implant Litigation is presided over by Judge Robert L. Miller, Jr. The total number of cases filed our 2883 altogether, and there are no new currently pending cases in the MDL. [2] As an update, a great majority of the cases have already been paid or dismissed due to the statute of limitations. The company agreed to settle most of the lawsuits for around $56 million. For example, In the fall of 2020, a Missouri federal jury awarded the plaintiff in a Biomet Magnum hip implant case $21 million in compensatory damages. Furthermore, in 2021 a 3.55 million dollar verdict was given to an Iowa woman.[4]

The Zimmer Versys Femoral Head, M/L Taper Hip Prothesis, and Kinectiv Technology are other types of hip implants that were also recalled. In the case of the M/L Taper Hip Prostheses, the utilization of titanium alloy and metal on metal construction led to the eventual recall, whereas the Versys Femoral Heads (made of a cobalt-chromium alloy) were another type. [1] The Zimmer Versys Hip Femoral Head and Zimmer M/L Taper Hip Prosthesis are alleged to be obviously flawed and dangerously incompatible when implanted together, with a proclivity to corrode between the components. Currently, there are about 292 cases pending out of 300 total actions. The MDL is presided before Judge Paul Crotty in the Southern District of New York. [2]

Michael Brady Lynch Firm

Here at the Michael Brady Lynch firm, we litigate strict product liability cases such as the Zimmer Biomet defective hip implant device. If you or a loved one have been injured by an implant device, please call us at 888-585-5970.

Date: July 22, 2022

Author: Brandon Salter

Citations

[1] https://www.consumeralertnow.com/defective-devices/zimmer-hips-shoulder-knee

[2] https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-Jul-15-2022.pdf

[3]https://www.drugwatch.com/hipreplacement/biomet/lawsuits/#:~:text=Hundreds%20of%20people%20filed%20lawsuits,the%20lawsuits%20for%20%2456%20million.

[4] https://pinellas.legalexaminer.com/legal/biomet-magnum-metal-hip-implant-jury-verdict-of-3-55-million-upheld-by-trial-judge/

Ormond Beach Abuse Investigation: Riverbend Academy

Ormond Beach Abuse Investigation: Riverbend Academy

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
PFAS Lawsuit 2025 Update: What You Should Know

PFAS Lawsuit 2025 Update: What You Should Know

The PFAS multidistrict litigation (MDL No. 2873) is moving forward in the District of South Carolina, where over 10,000 cases remain active against major manufacturers like 3M, DuPont, and BASF. While 3M reached a $10 billion settlement in 2023 to resolve water utility claims, no global settlement has been reached for individual personal injury lawsuits.

read more
Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax (alendronate), a widely used osteoporosis drug, remains the subject of multidistrict litigation (MDL) over allegations that it can cause serious bone injuries, including atypical femur fractures and osteonecrosis of the jaw (ONJ). Plaintiffs claim Merck failed to warn users adequately about these risks.

read more
Paragard MDL Updates: What You Should Know

Paragard MDL Updates: What You Should Know

The Paragard IUD remains the subject of a major nationwide lawsuit, with claims alleging the device breaks during removal, leading to serious injuries that the manufacturers, Teva Pharmaceuticals, allegedly failed to adequately warn consumers about. These cases have been centralized in Multidistrict Litigation (MDL) No. 2974, in the Northern District of Georgia.

read more
Understanding the Pre-Litigation Process: What to Do After a Car Accident

Understanding the Pre-Litigation Process: What to Do After a Car Accident

The time period immediately following a car accident is crucial not only for your health, but for protecting your legal rights. Prior to any lawsuits being filed, you enter the pre-litigation phase during which critical steps must be taken. Knowing what to do after an accident can make a major difference in the outcome of your personal injury claim and help preserve your right to compensation.

read more
The Car Accident Negotiation Phase

The Car Accident Negotiation Phase

The negotiation phase after a car accident is often the toughest part of resolving your claim. Insurance companies are skilled at minimizing payouts and may challenge the seriousness of your injuries, the necessity of your medical treatment, or the legitimacy of your lost wages. Getting through this process requires more than patience, it demands strong documentation and experienced legal representation.

read more
×
What Our Clients Are Saying